A Jorge Padilla. Revisiting dynamic duopoly with consumer switching costs. Journal of Economic Theory, 67: 520–530, 1995.
Aidan Hollis. The importance of being first: evidence from canadian generic pharmaceuticals. Health Economics, 11: 723–734, 2002. Aljoscha Janssen. Switching costs, quality misconceptions and behavioral pricing in the pharmaceutical market.
Alan Beggs and Paul Klemperer. Multi-period competition with switching costs. Econometrica, pages 651–666, 1992.
Alan T Sorensen. Equilibrium price dispersion in retail markets for prescription drugs. Journal of Political Economy, 108(4):833–850, 2000.
Andrea Amelio and Sara Biancini. Alternating monopoly and tacit collusion. The Journal of Industrial Economics, 58:402–423, 2010.
- Andrew F Daughety and Robert Forsythe. Complete information outcomes without common knowledge. In Proceedings of the 2nd conference on Theoretical aspects of reasoning about knowledge, pages 195–209. Morgan Kaufmann Publishers Inc., 1988.
Paper not yet in RePEc: Add citation now
Andrew Rhodes. Re-examining the effects of switching costs. Economic Theory, 57:161–194, 2014.
Bart J Bronnenberg, Jean-Pierre Dubé, Matthew Gentzkow, and Jesse M Shapiro. Do pharmacists buy bayer? informed shoppers and the brand premium. The Quarterly Journal of Economics, 130:1669–1726, 2015.
- Bloomberg. U.s. charges in generic-drug probe to be filed by year-end. https: // www. bloomberg. com/ news/ articles/ 2016-11-03/ u-s-charges-in-generic-drug-probe-said-to-be-filed-by-year-end , 2016. Accessed: 2017-02-23.
Paper not yet in RePEc: Add citation now
- com/ business/ la-fi-mylan-price-hikes-20160830-snap-story. html , 2016. Accessed: 2017-02-23.
Paper not yet in RePEc: Add citation now
David Granlund and Niklas Rudholm. Consumer loyalty in the swedish pharmaceutical market. Umeå Economic Studies, 742, 2008.
David Granlund. Price and welfare effects of a pharmaceutical substitution reform. Journal of Health Economics, 29: 856–865, 2010.
Eric Maskin and Jean Tirole. A theory of dynamic oligopoly, ii: Price competition, kinked demand curves, and edgeworth cycles. Econometrica, pages 571–599, 1988.
Eric Maskin and Jean Tirole. Markov perfect equilibrium: I. observable actions. Journal of Economic Theory, 100: 191–219, 2001.
Eric T Anderson and Nanda Kumar. Price competition with repeat, loyal buyers. Quantitative Marketing and Economics, 5:333–359, 2007.
Eric T Anderson, Nanda Kumar, and Surendra Rajiv. A comment on:“revisiting dynamic duopoly with consumer switching costsâ€Â. Journal of Economic Theory, 116:177–186, 2004.
- Eric T. Anderson. Essays on pricing and advertising. Dissertation. MIT Press, Cambridge, MA, 1995.
Paper not yet in RePEc: Add citation now
Francisco Ruiz-Aliseda. When do switching costs make markets more or less competitive? International Journal of Industrial Organization, 47:121–151, 2016.
Gregory S Crawford and Matthew Shum. Uncertainty and learning in pharmaceutical demand. Econometrica, 73: 1137–1173, 2005.
Guy Arie and Paul LE Grieco. Who pays for switching costs? Quantitative Marketing and Economics, 12:379–419, 2014.
- Handbook of industrial organization, 3:1967–2072, 2007.
Paper not yet in RePEc: Add citation now
J Miguel Villas-Boas. Dynamic competition with experience goods. Journal of Economics & Management Strategy, 15:37–66, 2006.
- Jadwiga Cletus. Investigation of bid collusion within the swedish generic drugs market. Master Thesis. University of Gothenburg. https: // gupea. ub. gu. se/ handle/ 2077/ 46761 , 2016. Accessed: 2017-02-23.
Paper not yet in RePEc: Add citation now
- Jean-Pierre Dubé, Günter J Hitsch, and Peter E Rossi. Do switching costs make markets less competitive? Journal of Marketing Research, 46:435–445, 2009.
Paper not yet in RePEc: Add citation now
Jean-Pierre Dubé, Günter J Hitsch, and Peter E Rossi. State dependence and alternative explanations for consumer inertia. RAND Journal of Economics, 41:417–445, 2010.
- Jennifer A Pereira, Anne M Holbrook, Lisa Dolovich, Charles Goldsmith, Lehana Thabane, James D Douketis, Mark Crowther, Shannon M Bates, and Jeffrey S Ginsberg. Are brand-name and generic warfarin interchangeable? a survey of ontario patients and physicians. The Canadian Journal of Clinical Pharmacology, 12:e229–e239, 2005. Frederik Plum Hauschultz and Anders Munk-Nielsen. Priscykler i markedet for receptpligtig medicin efter patentudlob.
Paper not yet in RePEc: Add citation now
Joel Sobel. The timing of sales. The Review of Economic Studies, 51:353–368, 1984.
John Conlisk, Eitan Gerstner, and Joel Sobel. Cyclic pricing by a durable goods monopolist. The Quarterly Journal of Economics, 99:489–505, 1984.
Joseph Doyle, Erich Muehlegger, and Krislert Samphantharak. Edgeworth cycles revisited. Energy Economics, 32: 651–660, 2010.
- Josh Feng. History-dependent demand and intermediaries: explaining prescription drug pricing dynamics. Unpublished, 2017.
Paper not yet in RePEc: Add citation now
- Karolina Andersson, Christian Sonesson, Max Petzold, Anders Carlsten, and Knut Lönnroth. What are the obstacles to generic substitution? an assessment of the behaviour of prescribers, patients and pharmacies during the first year of generic substitution in sweden. Pharmacoepidemiology and Drug Safety, 14:341–348, 2005.
Paper not yet in RePEc: Add citation now
- Konkurrence- og Forbrugerstyrelsen: Velfungerende markeder, pages 1–8, 2017.
Paper not yet in RePEc: Add citation now
Luis Cabral. Dynamic pricing in customer markets with switching costs. Review of Economic Dynamics, 20:43–62, 2016. 48 ∂ p ∂θ > 0 in Proposition 1. 49See p of Proposition 4. 50 ∂ p ∂θ > 0 in Proposition 3.
- Mats Bergman, David Granlund, and Niklas Rudholm. Apoteksmarknadens omreglering - effekter på följsamhet, priser och kostnader per dygnsdos. Tillvaextanalys, Workingpaper 19, 2012.
Paper not yet in RePEc: Add citation now
Matthew Shum. Does advertising overcome brand loyalty? evidence from the breakfast-cereals market. Journal of Economics & Management Strategy, 13:241–272, 2004.
Michael D Noel. Edgeworth price cycles, cost-based pricing, and sticky pricing in retail gasoline markets. The Review of Economics and Statistics, 89:324–334, 2007a.
- Michael D Noel. Edgeworth price cycles: Evidence from the toronto retail gasoline market. The Journal of Industrial Economics, 55:69–92, 2007b.
Paper not yet in RePEc: Add citation now
Michael P Keane. Modeling heterogeneity and state dependence in consumer choice behavior. Journal of Business & Economic Statistics, 15:310–327, 1997.
- Mohamed Azmi Hassali, David Kong, and Kay Stewart. Generic medicines: perceptions of consumers in melbourne, australia. International Journal of Pharmacy Practice, 13:257–264, 2005.
Paper not yet in RePEc: Add citation now
Natalia Fabra and Alfredo GarcÃÂa. Market structure and the competitive effects of switching costs. Economics Letters, 126:150–155, 2015. Joseph Farrell and Paul Klemperer. Coordination and lock-in: Competition with switching costs and network effects.
Oleksandr Shcherbakov. Measuring consumer switching costs in the television industry. RAND Journal of Economics, 47:366–393, 2016.
Oz Shy. A quick-and-easy method for estimating switching costs. International Journal of Industrial Organization, 20:71–87, 2002.
Paul Klemperer. Markets with consumer switching costs. The Quarterly Journal of Economics, 102:375–394, 1987b. Los Angeles Times. Here’s why drug prices rise even when there’s plenty of competition. http: // www. latimes.
Paul Klemperer. The competitiveness of markets with switching costs. RAND Journal of Economics, pages 138–150, 1987a.
Paul S Calem and Loretta J Mester. Consumer behavior and the stickiness of credit-card interest rates. The American Economic Review, 85(5):1327–1336, 1995. Robert Clark and Jean-Fran Houde. Collusion with asymmetric retailers: Evidence from a gasoline price-fixing case.
Prajit Dutta, Alexander Matros, and Jörgen W Weibull. Long-run price competition. RAND Journal of Economics, 38:291–313, 2007.
Richard G Frank and David S Salkever. Generic entry and the pricing of pharmaceuticals. Journal of Economics & Management Strategy, 6:75–90, 1997. Henry G Grabowski. Longer patents for increased genetic competition: The waxman-hatch act after one decade.
Richard G Frank and David S Salkever. Pricing, patent loss and the market for pharmaceuticals. Technical report, 1991.
- Robert H Porter. Detecting collusion. Review of Industrial Organization, 26:147–167, 2005.
Paper not yet in RePEc: Add citation now
- TLV. Apotekens marginaler. http: // www. tlv. se/ apotek/ Apotekens-marginaler/ , 2016d. Accessed: 201702 -23.
Paper not yet in RePEc: Add citation now
- TLV. Läkemedelsmarknaden. http: // www. tlv. se/ lakemedel/ Lakemedelsmarknaden/ , 2016a. Accessed: 2017-02-23.
Paper not yet in RePEc: Add citation now
- TLV. Pris och subvention av läkemedel. http: // www. tlv. se/ lakemedel/ pris-och-subvention-av-lakemedel/ , 2016e. Accessed: 2017-02-23.
Paper not yet in RePEc: Add citation now
- TLV. Takpriser. http: // www. tlv. se/ lakemedel/ takpriser/ , 2016b. Accessed: 2017-02-23.
Paper not yet in RePEc: Add citation now
Tracy L Regan. Generic entry, price competition, and market segmentation in the prescription drug market. International Journal of Industrial Organization, 26:930–948, 2008.
- Uwe Reinhardt. On the wondrous u.s. market for prescription drugs. The Health Care Blog, http: // thehealthcareblog. com/ blog/ 2016/ 09/ 04/ on-the-wondrous-u-s-market-for-prescription-drugs/ , 2016. Accessed: 2017-02-23.
Paper not yet in RePEc: Add citation now
V Brian Viard. Do switching costs make markets more or less competitive? the case of 800-number portability. RAND Journal of Economics, 38:146–163, 2007.